RT Book, Section A1 Nadler, Paul L. A1 Gonzales, Ralph A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. SR Print(0) ID 1193124279 T1 Fatigue & Systemic Intolerance Disease (Chronic Fatigue Syndrome) T2 Current Medical Diagnosis & Treatment 2023 YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264687343 LK accessmedicine.mhmedical.com/content.aspx?aid=1193124279 RD 2024/11/09 AB Key Clinical Updates in Fatigue & Systemic Intolerance Disease (Chronic Fatigue Syndrome)Pitolisant, a selective histamine H3 receptor antagonist with wake-promoting effect, may reduce daytime sleepiness in patients with moderate to severe obstructive sleep apnea who do not want continuous positive airway pressure treatment.Dauvilliers Y et al. Am J Respir Crit Care Med. [PMID: 31917607]